<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>From January 1991 to March 2007, 61 children and adolescent with acquired severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> received BMT in our institutions </plain></SENT>
<SENT sid="1" pm="."><plain>We retrospectively compared the outcome of 30 cases of matched-sibling donor BMT (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSD</z:e>-BMT) and 31 cases of unrelated donor BMT (URD-BMT) </plain></SENT>
<SENT sid="2" pm="."><plain>We observed one graft failure among <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSD</z:e>-BMT recipients and three graft failures among URD-BMT recipients, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>No patients in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSD</z:e>-BMT group developed grades II-IV <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD compared with 11 of 30 patients (37%) in the URD-BMT group (P&lt;0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>One of 30 MSD-BMT recipients (3%) developed <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD compared with 8 of 30 URD-BMT recipients (27%) (P=0.013) </plain></SENT>
<SENT sid="5" pm="."><plain>The incidence of EBV and CMV reactivation was 11 of 20 URD-BMT recipients and 23 of 30, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>One patient in the URD-BMT group died of a motor accident 5.5 years after BMT </plain></SENT>
<SENT sid="7" pm="."><plain>Ten-year OS was 100% in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSD</z:e>-BMT recipients and 93.8% (95% CI, 81.9-100%) in URD-BMT recipients, respectively (P=0.252) </plain></SENT>
<SENT sid="8" pm="."><plain>Ten-year failure-free survival was 96.7% (95% CI, 90.2-100%) in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSD</z:e>-BMT group and 84.7% (95% CI, 70.2-99.2%) in the URD-BMT group, respectively (P=0.161) </plain></SENT>
</text></document>